Have a personal or library account? Click to login
Deficyt aktywności transaldolazy – Obraz kliniczny, patogeneza, diagnostyka Cover

Deficyt aktywności transaldolazy – Obraz kliniczny, patogeneza, diagnostyka

Open Access
|Jun 2018

References

  1. Perl A, Qian Y, Chohan KR, Shirley CR, Amidon W, Banerjee S, Middleton FA, Conkrite KL, Barcza M, Gonchoroff N, Suarez SS, Banki K. Transaldolase is essential for maintenance the mitochondrial transmembrane potential and fertility of spermatozoa. Proc Natl Acad Sci USA 2006;103:1481314818.
  2. Perl A. The pathogenesis of transaldolase deficiency. IUBMB Life 2007;59:365-373.
  3. Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, Olin-Sandoval V, Grüning NM, Krüger A, Tauqeer Alam M, Keller M, Breitenbach M, Brindle KM, Rabinowitz Jd, Ralser M. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc. 2015;90: 927-963.
  4. Verhoeven NM, Huck JH, Roos B, Struys EA, Salomons GS, Douwes AC, Jakobs C. Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet. 2001;68:1086-1092.
  5. Loeffen YG, Biebuyck N, Wamelink MM, Jakobs C, Mulder MF, Tylki-Szymańska A, Bökenkamp A. Nephrological abnormalities in patients with transaldolase deficiency. Nephrol Dial Transplant. 2012;27:3224-3227.
  6. Verhoeven NM, Wallot M, Huck JH, Dirsch O, Ballauf A, Neudorf U, Jakobs C. A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis. 2005;28:169-179.
  7. Valayonnopoulos V, Verhoeven NM, Mention K, Salomons GA, Sommelet D, Gonzales M, Touati G, de Lyonalay P, Jakobs C, Saudubray JM. Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. Pediatrics 2006;149:713-717.
  8. Balasubramaniam S, Wamelink MM, Ngu LH, Talib A, Salomons GS, Jakobs C, Keng WT. Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr. 2011;52:113-116.
  9. Wamelink MM, Struys EA, Salomons GS, Fowler D, Jakobs C, Clayton PT. Transaldolase deficiency in a two-year-old boy with cirrhosis. Mol Genet Metab. 2008;94:255-258.
  10. Tylki-Szymanska A, Stradomska TJ, Wamelink MM, Salomons GS, Taybert J, Pawłowska J, Jakobs C. Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab. 2009;97:15-17.
  11. Eyaid W, Al Harbi T, Anazi S, Wamelink MM, Jakobs C, Al Salammah M, Alkuraya FS. Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. J Inherit Metab Dis. 2013;36:997-1004.
  12. LeDuc CA, Crouch EE, Wilson A, Lefkowitch J, Wamelink MMC, Jakobs C, Salomons GS, Sun X, Shen Y, Chung WK.Novel association of early onset hepatocellular carcinoma with transaldolase deficiency. JIMD Rep. 2014;12:121-127.
  13. Tylki-Szymanska A,Wamelink MM, Stradomska TJ, Salomons GS, Taybert J, Dąbrowska-Leonik N, Rurarz M. Clinical and molecular characteristics of two transaldolase-deficient patients. Eur J Pediatr. 2014;173:1679-1682.
  14. Jassim N, Alghaihab M, Saleh SA, Alfadhel M, Wamelink MM, Eyaid W. Pulmonary manifestations in a patient with transaldolase deficiency. JIMD Rep. 2014;12:47-50.
  15. Al-Shamsi AM, Ben-Salem S, Hertecant J, Al-Jasmi F. Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability. Eur J Pediatr. 2015;174:661-668.
  16. Banne E, Meiner V, Shaag A, Katz-Brull R, Gamliel A, Korman S, Cederboim SH, Duvdevani MP, Frumkin A, Zilkha A, Kapuller V, Arbell D, Cohen E, Eventov-Friedman S. Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum. JIMD Rep. 2016;26:31-36.
  17. Rodan LH, Berry GT. N-Acetylcysteine therapy in an infant with transaldolase deficiency is well tolerated and associated with normalization of alpha fetoprotein levels. JIMD Rep. 2017;31:73-77.
  18. Lipiński P, Pawłowska P, Stradomska TJ, Ciara E, Jankowska I, Socha P, Tylki-Szymańska A Long-term systematic monitoring of four Polish transaldolase deficient patients. JIMD Rep 2018 (in press). doi:10.1007/8904_2017_83
  19. Wamelink MM, Smith DE, Jansen EE, Verhoeven NM, Struys EA, Jakobs C. Detection of transaldolase deficiency by quantification of novel seven carbon chain carbohydrate biomarkers in urine. J Inherit Metab Dis. 2007;30:735-742.
  20. Wamelink MM, Smith DE, Jakobs C, Verhoeven NM. Analysis of polyols in urine by liquid chromatographytandem mass spectrometry: a useful tool for recognition of inborn errors affecting polyol metabolism. J Inherit Metab Dis. 2005;28:951-963.
  21. Wamelink MM, Struys EA, Huck JH, Roos B, van der Knaap MS, Jakobs C, Verhoeven NM. Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism. J Chromatogr B Anal Technol Biomed Life Sci. 2005;823:18-25.
  22. Stradomska TJ, Mileniczuk Z. Gas chromatographic determination of D-/L-arabinitol ratio in healthy Polish children. J Chromatogr B Nal Technol Biomed Life Sci. 2002;773:175-181.
DOI: https://doi.org/10.34763/devperiodmed.20182202.187196 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488
Language: English
Page range: 187 - 196
Submitted on: Feb 7, 2018
Accepted on: Apr 17, 2018
Published on: Jun 30, 2018
Published by: Institute of Mother and Child
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2018 Patryk Lipiński, Teresa Stradomska, Anna Tylki-Szymańska, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.